Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
- Status
- COMPLETED
- Phase
- PHASE1
Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.
- Status
- TERMINATED
- Phase
- PHASE2
Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey
- Status
- COMPLETED
- Phase
- N/A
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Feasibility of Fasting & Exercise in Pts With HR+ MBC
- Status
- COMPLETED
- Phase
- NA
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Nurse AMIE for Echo Show: Randomized Control Trial
- Status
- COMPLETED
- Phase
- NA
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
- Status
- COMPLETED
- Phase
- N/A
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC
- Status
- UNKNOWN
- Phase
- N/A
ImmunoBreast - A Phase Ib Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A